AstraZeneca: Expert says suspension could 'dent confidence'
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
Multiple countries in the European Union have suspended injections of the British-developed jab, after concerns over serious side-effects in people in Denmark and Norway. There were claims of bleeding and blood clots in a small number of people who had the AstraZeneca jab.
While the European Medicines Agency and World Health Organisation has said there is no indication that the events were caused by the vaccination, multiple EU states have blocked the use of the jab.
This afternoon the Prime Minister’s official spokesman criticised the decision, saying there was no evidence to support the suspension.
He said: “The Oxford/AstraZeneca vaccine remains both safe and effective.
“There is no evidence of any kind casual link between blood clots and the AstraZeneca vaccine.
“Blood clots occur naturally and there is no evidence they are any more likely to occur following vaccination.”
Denmark, Norway, Ireland, Iceland and Thailand have halted use of the Oxford vaccine over blood clotting concerns.
With fears the news of the suspension of the vaccine in countries abroad could undermine trust in the jab, the No10 official said anyone in the UK offered the Oxford injection should book an appointment.
He said: “We urge anybody asked to come forward to receive a vaccine to do so.
“You’ll have seen again over the weekend we’re continuing the vaccination programme with hundreds of thousands more people having now received a vaccine.
“We’ll continue to make sure it’s available to make sure we can hit our target to vaccinate all those phase one groups by mid-April.”
More to follow…
Source: Read Full Article